Opinion: Page 2

The latest opinion pieces by industry thought leaders

If you are interested in having your voice heard on PharmaVoice's Opinion page, please read our editorial guidelines and fill out the submission form here.

  • computer keyboard test tube
    Image attribution tooltip
    Retrieved from Google image.
    Image attribution tooltip

    Industry executives predict the next 'blue oceans' in pharma

    Where life science leaders see breakthroughs happening in the industry.

    Taren Grom • Feb. 4, 2022
  • Three people are having an in-office meeting
    Image attribution tooltip
    Pekic via Getty Images
    Image attribution tooltip

    Talent acquisition stays top of mind for pharma execs

    From creating flexible work environments to looking outside the industry for new talent, pharma execs are shifting strategies to keep their teams afloat.

    Taren Grom • Feb. 1, 2022
  • Image attribution tooltip
    Ricardo Ceppi via Getty Images
    Image attribution tooltip

    Biopharma's R&D leaders on how technology can accelerate drug development

    How emerging digital tools are providing enhanced clinical insights and improved trial results.

    Taren Grom • Jan. 27, 2022
  • man in suit patient figures magnifying glass
    Image attribution tooltip
    Retrieved from Google image.
    Image attribution tooltip

    Leaders predict improving patient engagement will lead to growth opportunities

    Why patient engagement is key to successful business growth.

    Taren Grom • Jan. 24, 2022
  • man in suit patient figures magnifying glass
    Image attribution tooltip
    Retrieved from Google image.
    Image attribution tooltip

    Pharma execs reveal the industry's most pressing issues

    Several market factors — including COVID — are driving changes and trends in the industry.

    Taren Grom • Jan. 14, 2022
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Speak Out: The Value of Using Neutral Analysis in Life Sciences Disputes

    Imagine that you have multiple published and peer-reviewed clinical trials and time is of the essence to get your vaccine to market. Unfortunately, you are involved in a lawsuit for patent infringement with a competitor. Will you go to trial? What are your odds of prevailing? HAVE THE RIGHT ST...

    Hon. Gregory M. Sleet (Ret.) • Nov. 15, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Executive Perspective: Data For Better Health Outcomes: A Conversation with Clark Wooten and Anthony Passarelli

    The COVID-19 pandemic has continued to disrupt the healthcare market across all sectors, and the digital health segment is no exception. But in this case, there has been a positive boost. According to Global Market Insights, the digital health market exceeded $141.8 billion in 2020 and is estimat...

    Clark Wooten • Nov. 15, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Executive Perspective: The Right Man for the Job A Conversation with Andy Plump, M.D., Ph.D.

    Timing in life is everything, and for Andy Plump, M.D., Ph.D., taking on the role as president of R&D at Takeda in 2015 has proven to be advantageous not only for the 239-year-old company at a time when it needed a fresh approach, but also for patients around the globe. Back in 2014, Andy ...

    Dr. Andy Plump • Jan. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Speak Out: From Crawl to Run: Maturing Digital Engagement

    In the last 5 years, the pharmaceutical industry has taken clear steps towards omnichannel engagement. In the last 5 months, the walking — and sometimes crawling — has turned into a race. And not everyone is ready to run. The core drivers of success in pharmaceutical sales have not...

    Antonio Pregueiro • Sept. 1, 2020